Disease or syndrome,Drug(s),Pharmacological class,Rationale,Recommendation,Quality of evidence,"Strength of
recommendation"
Heart failure,Cilostazol,Antiplatelet agents,Potential to increase mortality in older adults with heart failure.,Avoid,Low,Strong
Heart failure,Dextromethorphan/quinidine,N-Methyl-D-Aspartate receptor agonists,Concerns about QT prolongation.,Avoid,Low,Strong
Heart failure,Diltiazem,Nondihydropyridine calcium channel blockers,Potential to promote fluid retention and/or exacerbate heart failure.,Avoid in heart failure with reduced ejection fraction.,Moderate,Strong
Heart failure,Verapamil,Nondihydropyridine calcium channel blockers,Potential to promote fluid retention and/or exacerbate heart failure.,Avoid in heart failure with reduced ejection fraction.,Moderate,Strong
Heart failure,Dronedarone,Antiarrhythmics,Potential to increase mortality in older adults with heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,High,Strong
Heart failure,Celecoxib,"Non-steroidal anti-inflammatory drugs, COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Low,Strong
Heart failure,Etoricoxib,"Non-steroidal anti-inflammatory drugs, COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Low,Strong
Heart failure,Parecoxib,"Non-steroidal anti-inflammatory drugs, COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Low,Strong
Heart failure,Aspirin,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Diclofenac,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Ibuprofen,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Indomethacin,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Ketoprofen,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Naproxen,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Mefenamic acid,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Piroxicam,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Diflunisal,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Etodolac,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Flurbiprofen,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Ketorolac,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Meloxicam,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Choline salicylate,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Methyl salicylate,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Sodium salicylate,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Dexketoprofen,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Aceclofenac,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Nabumetone,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Oxaprozin,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Sulindac,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Fenoprofen,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Phenylbutazone,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Meclofenamic acid,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Meclofenamate,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,Moderate,Strong
Heart failure,Pioglitazone,Thiazolidinediones ,Potential to promote fluid retention and/or exacerbate heart failure.,Use with caution in patients with heart failure who are asymptomatic; avoid in patients with symptomatic heart failure.,High,Strong
Syncope,Chlorpromazine,Antipsychotics,Increase risk of orthostatic hypotension.,Avoid,High,Weak
Syncope,Olanzapine,Antipsychotics,Increase risk of orthostatic hypotension.,Avoid,High,Weak
Syncope,Donepezil,Cholinesterase inhibitors,Cause bradycardia; Should be avoided in older adults whose syncope may be due to bradycardia.,Avoid,High,Strong
Syncope,Galantamine,Cholinesterase inhibitors,Cause bradycardia; Should be avoided in older adults whose syncope may be due to bradycardia.,Avoid,High,Strong
Syncope,Rivastigmine,Cholinesterase inhibitors,Cause bradycardia; Should be avoided in older adults whose syncope may be due to bradycardia.,Avoid,High,Strong
Syncope,Doxazosin,Non-selective peripheral alpha-1 blockers,Cause orthostatic blood pressure changes; Should be avoided in older adults whose syncope may be due to orthostatic hypotension.,Avoid,High,Weak
Syncope,Prazosin,Non-selective peripheral alpha-1 blockers,Cause orthostatic blood pressure changes; Should be avoided in older adults whose syncope may be due to orthostatic hypotension.,Avoid,High,Weak
Syncope,Terazosin,Non-selective peripheral alpha-1 blockers,Cause orthostatic blood pressure changes; Should be avoided in older adults whose syncope may be due to orthostatic hypotension.,Avoid,High,Weak
Syncope,Amitriptyline,Tricyclic antidepressants,Increase risk of orthostatic hypotension.,Avoid,High,Strong
Syncope,Clomipramine,Tricyclic antidepressants,Increase risk of orthostatic hypotension.,Avoid,High,Strong
Syncope,Doxepin,Tricyclic antidepressants,Increase risk of orthostatic hypotension.,Avoid,High,Strong
Syncope,Imipramine,Tricyclic antidepressants,Increase risk of orthostatic hypotension.,Avoid,High,Strong
Delirium,Amitriptyline,Tricyclic antidepressants,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Amoxapine,Tricyclic antidepressants,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Clomipramine,Tricyclic antidepressants,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Desipramine,Tricyclic antidepressants,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Doxepin,Tricyclic antidepressants,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid >6 mg/day, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Imipramine,Tricyclic antidepressants,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Nortriptyline,Tricyclic antidepressants,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Paroxetine,Selective serotonin re-uptake inhibitors,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Prochlorperazine,Antiemetics,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Promethazine,"Antiemetics, First-generation antihistamines",Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Brompheniramine,First-generation antihistamines,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Chlorpheniramine,First-generation antihistamines,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Cyproheptadine,First-generation antihistamines,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Dimenhydrinate,First-generation antihistamines,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Diphenhydramine,First-generation antihistamines,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Doxylamine,First-generation antihistamines,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Hydroxyzine,First-generation antihistamines,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Meclizine,First-generation antihistamines,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Triprolidine,First-generation antihistamines,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Darifenacin,Antimuscarinics,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Fesoterodine,Antimuscarinics,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Flavoxate,Antimuscarinics,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Oxybutynin,Antimuscarinics,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Solifenacin,Antimuscarinics,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Tolterodine,Antimuscarinics,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Trospium,Antimuscarinics,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Benztropine,Antiparkinsonian agents,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Trihexyphenidyl,Antiparkinsonian agents,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Chlorpromazine,Antipsychotics,"Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium. 
Avoid for behavioral problems of dementia or delirium unless nonpharmacologic options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Clozapine,Antipsychotics,"Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium. 
Avoid for behavioral problems of dementia or delirium unless nonpharmacologic options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Olanzapine,Antipsychotics,"Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium. 
Avoid for behavioral problems of dementia or delirium unless nonpharmacologic options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Perphenazine,Antipsychotics,"Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium. 
Avoid for behavioral problems of dementia or delirium unless nonpharmacologic options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Fluphenazine,Antipsychotics,"Avoid for behavioral problems of dementia or delirium unless nonpharmacologic options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Haloperidol,Antipsychotics,"Avoid for behavioral problems of dementia or delirium unless nonpharmacologic options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Aripiprazole,Antipsychotics,"Avoid for behavioral problems of dementia or delirium unless nonpharmacologic options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Brexpiprazole,Antipsychotics,"Avoid for behavioral problems of dementia or delirium unless nonpharmacologic options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Cariprazine,Antipsychotics,"Avoid for behavioral problems of dementia or delirium unless nonpharmacologic options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Lurasidone,Antipsychotics,"Avoid for behavioral problems of dementia or delirium unless nonpharmacologic options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Paliperidone,Antipsychotics,"Avoid for behavioral problems of dementia or delirium unless nonpharmacologic options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Pimavanserin,Antipsychotics,"Avoid for behavioral problems of dementia or delirium unless nonpharmacologic options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Quetiapine,Antipsychotics,"Avoid for behavioral problems of dementia or delirium unless nonpharmacologic options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Risperidone,Antipsychotics,"Avoid for behavioral problems of dementia or delirium unless nonpharmacologic options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Ziprasidone,Antipsychotics,"Avoid for behavioral problems of dementia or delirium unless nonpharmacologic options (eg, behavioral interventions) have failed or are not possible and the older adult is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Atropine,Antispasmodics,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Clidinium/chlordiazepoxide,Antispasmodics,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Dicyclomine,Antispasmodics,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Homatropine,Antispasmodics,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Hyoscyamine,Antispasmodics,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Scopolamine,Antispasmodics,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Cyclobenzaprine,Skeletal muscle relaxants,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Orphenadrine,Skeletal muscle relaxants,Strong anticholinergic properties; Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Alprazolam,Benzodiazepines ,Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Chlordiazepoxide,Benzodiazepines ,"Applicable for chlordiazepoxide alone/ in combination with amitriptyline or clidinium:
Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Clobazam,Benzodiazepines ,Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Clonazepam,Benzodiazepines ,Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Clorazepate,Benzodiazepines ,Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Diazepam,Benzodiazepines ,Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Estazolam,Benzodiazepines ,Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Lorazepam,Benzodiazepines ,Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Midazolam,Benzodiazepines ,Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Oxazepam,Benzodiazepines ,Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Temazepam,Benzodiazepines ,Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Triazolam,Benzodiazepines ,Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Flurazepam,Benzodiazepines ,Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Prednisone,Corticosteroids,"Oral:
If needed, use the lowest possible dose for the shortest duration and monitor for delirium.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Prednisolone,Corticosteroids,"Oral and parental:
If needed, use the lowest possible dose for the shortest duration and monitor for delirium.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Methylprednisolone,Corticosteroids,"Oral and parental:
If needed, use the lowest possible dose for the shortest duration and monitor for delirium.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Betamethasone,Corticosteroids,"Oral and parental:
If needed, use the lowest possible dose for the shortest duration and monitor for delirium.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Hydrocortisone,Corticosteroids,"Oral and parental:
If needed, use the lowest possible dose for the shortest duration and monitor for delirium.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Dexamethasone,Corticosteroids,"Oral and parental:
If needed, use the lowest possible dose for the shortest duration and monitor for delirium.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Triamcinolone,Corticosteroids,"Oral and parental:
If needed, use the lowest possible dose for the shortest duration and monitor for delirium.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Cortisone,Corticosteroids,"Oral and parental:
If needed, use the lowest possible dose for the shortest duration and monitor for delirium.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Deflazacort,Corticosteroids,"Oral:
If needed, use the lowest possible dose for the shortest duration and monitor for delirium.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Budesonide,Corticosteroids,"Oral:
If needed, use the lowest possible dose for the shortest duration and monitor for delirium.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Fludrocortisone,Corticosteroids,"Oral:
If needed, use the lowest possible dose for the shortest duration and monitor for delirium.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Cimetidine,H2-receptor antagonists,Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Low,Strong
Delirium,Famotidine,H2-receptor antagonists,Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Low,Strong
Delirium,Nizatidine,H2-receptor antagonists,Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Low,Strong
Delirium,Eszopiclone,"Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (""Z-drugs"") ",Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Zaleplon,"Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (""Z-drugs"") ",Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Zolpidem,"Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (""Z-drugs"") ",Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.,"Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Morphine,Opioids,"Emerging data highlights an association between opioid administration and delirium. 
For older adults with pain, use a balanced approach, including the use of validated pain assessment tools and multimodal strategies that include nondrug approaches to minimize opioid use.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Methadone,Opioids,"Emerging data highlights an association between opioid administration and delirium. 
For older adults with pain, use a balanced approach, including the use of validated pain assessment tools and multimodal strategies that include nondrug approaches to minimize opioid use.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Oxycodone,Opioids,"Emerging data highlights an association between opioid administration and delirium. 
For older adults with pain, use a balanced approach, including the use of validated pain assessment tools and multimodal strategies that include nondrug approaches to minimize opioid use.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Fentanyl,Opioids,"Emerging data highlights an association between opioid administration and delirium. 
For older adults with pain, use a balanced approach, including the use of validated pain assessment tools and multimodal strategies that include nondrug approaches to minimize opioid use.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Hydrocodone,Opioids,"Emerging data highlights an association between opioid administration and delirium. 
For older adults with pain, use a balanced approach, including the use of validated pain assessment tools and multimodal strategies that include nondrug approaches to minimize opioid use.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Codeine,Opioids,"Emerging data highlights an association between opioid administration and delirium. 
For older adults with pain, use a balanced approach, including the use of validated pain assessment tools and multimodal strategies that include nondrug approaches to minimize opioid use.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Tramadol,Opioids,"Emerging data highlights an association between opioid administration and delirium. 
For older adults with pain, use a balanced approach, including the use of validated pain assessment tools and multimodal strategies that include nondrug approaches to minimize opioid use.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Oxymorphone,Opioids,"Emerging data highlights an association between opioid administration and delirium. 
For older adults with pain, use a balanced approach, including the use of validated pain assessment tools and multimodal strategies that include nondrug approaches to minimize opioid use.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Buprenorphine,Opioids,"Emerging data highlights an association between opioid administration and delirium. 
For older adults with pain, use a balanced approach, including the use of validated pain assessment tools and multimodal strategies that include nondrug approaches to minimize opioid use.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Hydromorphone,Opioids,"Emerging data highlights an association between opioid administration and delirium. 
For older adults with pain, use a balanced approach, including the use of validated pain assessment tools and multimodal strategies that include nondrug approaches to minimize opioid use.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Tapentadol,Opioids,"Emerging data highlights an association between opioid administration and delirium. 
For older adults with pain, use a balanced approach, including the use of validated pain assessment tools and multimodal strategies that include nondrug approaches to minimize opioid use.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Remifentanil,Opioids,"Emerging data highlights an association between opioid administration and delirium. 
For older adults with pain, use a balanced approach, including the use of validated pain assessment tools and multimodal strategies that include nondrug approaches to minimize opioid use.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Alfentanil,Opioids,"Emerging data highlights an association between opioid administration and delirium. 
For older adults with pain, use a balanced approach, including the use of validated pain assessment tools and multimodal strategies that include nondrug approaches to minimize opioid use.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Pentazocine,Opioids,"Emerging data highlights an association between opioid administration and delirium. 
For older adults with pain, use a balanced approach, including the use of validated pain assessment tools and multimodal strategies that include nondrug approaches to minimize opioid use.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Delirium,Sufentanil,Opioids,"Emerging data highlights an association between opioid administration and delirium. 
For older adults with pain, use a balanced approach, including the use of validated pain assessment tools and multimodal strategies that include nondrug approaches to minimize opioid use.","Avoid, except in situations listed under the rationale statement.",Moderate,Strong
Dementia or cognitive impairment,Amitriptyline,Tricyclic antidepressants,"Strong anticholinergic properties, sedating, and cause orthostatic hypotension. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Amoxapine,Tricyclic antidepressants,"Strong anticholinergic properties, sedating, and cause orthostatic hypotension. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Clomipramine,Tricyclic antidepressants,"Strong anticholinergic properties, sedating, and cause orthostatic hypotension. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Desipramine,Tricyclic antidepressants,"Strong anticholinergic properties, sedating, and cause orthostatic hypotension. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Doxepin,Tricyclic antidepressants,"Strong anticholinergic properties, sedating, and cause orthostatic hypotension; the safety profile of low-dose doxepin (<=6 mg/day) is comparable to that of placebo. 
Avoid because of adverse CNS effects. ",Avoid >6 mg/day,Moderate,Strong
Dementia or cognitive impairment,Imipramine,Tricyclic antidepressants,"Strong anticholinergic properties, sedating, and cause orthostatic hypotension. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Nortriptyline,Tricyclic antidepressants,"Strong anticholinergic properties, sedating, and cause orthostatic hypotension. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Paroxetine,Selective serotonin re-uptake inhibitors,"Strong anticholinergic properties, sedating, and cause orthostatic hypotension. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Prochlorperazine,Antiemetics,"Strong anticholinergic properties; Dopamine-receptor antagonists with the potential to worsen parkinsonian symptoms. 
Avoid because of adverse CNS effects.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Promethazine,"Antiemetics, First-generation antihistamines","Strong anticholinergic properties.
Avoid because of adverse CNS effects.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Brompheniramine,First-generation antihistamines,"Strong anticholinergic properties. 
Avoid because of adverse CNS effects. 
See criteria (Table 2) on individual drugs for additional information.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Chlorpheniramine,First-generation antihistamines,"Strong anticholinergic properties. 
Avoid because of adverse CNS effects. 
See criteria (Table 2) on individual drugs for additional information.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Cyproheptadine,First-generation antihistamines,"Strong anticholinergic properties. 
Avoid because of adverse CNS effects. 
See criteria (Table 2) on individual drugs for additional information.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Dimenhydrinate,First-generation antihistamines,"Strong anticholinergic properties. 
Avoid because of adverse CNS effects. 
See criteria (Table 2) on individual drugs for additional information.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Diphenhydramine,First-generation antihistamines,"Strong anticholinergic properties. 
Avoid because of adverse CNS effects. 
See criteria (Table 2) on individual drugs for additional information.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Doxylamine,First-generation antihistamines,"Strong anticholinergic properties. 
Avoid because of adverse CNS effects. 
See criteria (Table 2) on individual drugs for additional information.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Hydroxyzine,First-generation antihistamines,"Strong anticholinergic properties. 
Avoid because of adverse CNS effects. 
See criteria (Table 2) on individual drugs for additional information.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Meclizine,First-generation antihistamines,"Strong anticholinergic properties. 
Avoid because of adverse CNS effects. 
See criteria (Table 2) on individual drugs for additional information.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Triprolidine,First-generation antihistamines,"Strong anticholinergic properties. 
Avoid because of adverse CNS effects. 
See criteria (Table 2) on individual drugs for additional information.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Darifenacin,Antimuscarinics,"Strong anticholinergic properties; May decrease urinary flow and cause urinary retention. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Fesoterodine,Antimuscarinics,"Strong anticholinergic properties; May decrease urinary flow and cause urinary retention. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Flavoxate,Antimuscarinics,"Strong anticholinergic properties; May decrease urinary flow and cause urinary retention. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Oxybutynin,Antimuscarinics,"Strong anticholinergic properties; May decrease urinary flow and cause urinary retention. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Solifenacin,Antimuscarinics,"Strong anticholinergic properties; May decrease urinary flow and cause urinary retention. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Tolterodine,Antimuscarinics,"Strong anticholinergic properties; May decrease urinary flow and cause urinary retention. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Trospium,Antimuscarinics,"Strong anticholinergic properties; May decrease urinary flow and cause urinary retention. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Benztropine,Antiparkinsonian agents,"Strong anticholinergic properties.
Avoid because of adverse CNS effects. 
Not recommended for prevention or treatment of extrapyramidal symptoms due to antipsychotics; more effective agents available for the treatment of Parkinson disease.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Trihexyphenidyl,Antiparkinsonian agents,"Strong anticholinergic properties.
Avoid because of adverse CNS effects. 
Not recommended for prevention or treatment of extrapyramidal symptoms due to antipsychotics; more effective agents available for the treatment of Parkinson disease.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Chlorpromazine,Antipsychotics,"Strong anticholinergic properties. 
Avoid because of adverse CNS effects. 
Increased risk of stroke and greater rate of cognitive decline and mortality in persons with dementia. Additional evidence suggests an association of increased risk between antipsychotic medication and mortality independent of dementia.
Avoid antipsychotics for behavioral problems of dementia or delirium unless documented nonpharmacologic options (e.g., behavioral interventions) have failed and/or the patient is threatening substantial harm to self or others. If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid.
May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",Moderate,Strong
Dementia or cognitive impairment,Clozapine,Antipsychotics,"Strong anticholinergic properties. 
Avoid because of adverse CNS effects. 
Increased risk of stroke and greater rate of cognitive decline and mortality in persons with dementia. Additional evidence suggests an association of increased risk between antipsychotic medication and mortality independent of dementia.
Avoid antipsychotics for behavioral problems of dementia or delirium unless documented nonpharmacologic options (e.g., behavioral interventions) have failed and/or the patient is threatening substantial harm to self or others. If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid.
May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",Moderate,Strong
Dementia or cognitive impairment,Olanzapine,Antipsychotics,"Strong anticholinergic properties. 
Avoid because of adverse CNS effects. 
Increased risk of stroke and greater rate of cognitive decline and mortality in persons with dementia. Additional evidence suggests an association of increased risk between antipsychotic medication and mortality independent of dementia.
Avoid antipsychotics for behavioral problems of dementia or delirium unless documented nonpharmacologic options (e.g., behavioral interventions) have failed and/or the patient is threatening substantial harm to self or others. If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid.
May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",Moderate,Strong
Dementia or cognitive impairment,Perphenazine,Antipsychotics,"Strong anticholinergic properties. 
Avoid because of adverse CNS effects. 
Increased risk of stroke and greater rate of cognitive decline and mortality in persons with dementia. Additional evidence suggests an association of increased risk between antipsychotic medication and mortality independent of dementia.
Avoid antipsychotics for behavioral problems of dementia or delirium unless documented nonpharmacologic options (e.g., behavioral interventions) have failed and/or the patient is threatening substantial harm to self or others. If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid.
May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",Moderate,Strong
Dementia or cognitive impairment,Fluphenazine,Antipsychotics,"Increased risk of stroke and greater rate of cognitive decline and mortality in people with dementia. 
Avoid antipsychotics for behavioral problems of dementia or delirium unless documented nonpharmacologic options (e.g., behavioral interventions) have failed and/or the patient is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid chronic use or persistent as-needed use.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",Moderate,Strong
Dementia or cognitive impairment,Haloperidol,Antipsychotics,"Increased risk of stroke and greater rate of cognitive decline and mortality in people with dementia. 
Avoid antipsychotics for behavioral problems of dementia or delirium unless documented nonpharmacologic options (e.g., behavioral interventions) have failed and/or the patient is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid chronic use or persistent as-needed use.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",Moderate,Strong
Dementia or cognitive impairment,Aripiprazole,Antipsychotics,"Increased risk of stroke and greater rate of cognitive decline and mortality in people with dementia. 
Avoid antipsychotics for behavioral problems of dementia or delirium unless documented nonpharmacologic options (e.g., behavioral interventions) have failed and/or the patient is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid chronic use or persistent as-needed use.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",Moderate,Strong
Dementia or cognitive impairment,Brexpiprazole,Antipsychotics,"Increased risk of stroke and greater rate of cognitive decline and mortality in people with dementia. 
Avoid antipsychotics for behavioral problems of dementia or delirium unless documented nonpharmacologic options (e.g., behavioral interventions) have failed and/or the patient is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid chronic use or persistent as-needed use.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",Moderate,Strong
Dementia or cognitive impairment,Cariprazine,Antipsychotics,"Increased risk of stroke and greater rate of cognitive decline and mortality in people with dementia. 
Avoid antipsychotics for behavioral problems of dementia or delirium unless documented nonpharmacologic options (e.g., behavioral interventions) have failed and/or the patient is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid chronic use or persistent as-needed use.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",Moderate,Strong
Dementia or cognitive impairment,Lurasidone,Antipsychotics,"Increased risk of stroke and greater rate of cognitive decline and mortality in people with dementia. 
Avoid antipsychotics for behavioral problems of dementia or delirium unless documented nonpharmacologic options (e.g., behavioral interventions) have failed and/or the patient is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid chronic use or persistent as-needed use.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",Moderate,Strong
Dementia or cognitive impairment,Paliperidone,Antipsychotics,"Increased risk of stroke and greater rate of cognitive decline and mortality in people with dementia. 
Avoid antipsychotics for behavioral problems of dementia or delirium unless documented nonpharmacologic options (e.g., behavioral interventions) have failed and/or the patient is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid chronic use or persistent as-needed use.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",Moderate,Strong
Dementia or cognitive impairment,Pimavanserin,Antipsychotics,"Increased risk of stroke and greater rate of cognitive decline and mortality in people with dementia. 
Avoid antipsychotics for behavioral problems of dementia or delirium unless documented nonpharmacologic options (e.g., behavioral interventions) have failed and/or the patient is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid chronic use or persistent as-needed use.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",Moderate,Strong
Dementia or cognitive impairment,Quetiapine,Antipsychotics,"Increased risk of stroke and greater rate of cognitive decline and mortality in people with dementia. 
Avoid antipsychotics for behavioral problems of dementia or delirium unless documented nonpharmacologic options (e.g., behavioral interventions) have failed and/or the patient is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid chronic use or persistent as-needed use.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",Moderate,Strong
Dementia or cognitive impairment,Risperidone,Antipsychotics,"Increased risk of stroke and greater rate of cognitive decline and mortality in people with dementia. 
Avoid antipsychotics for behavioral problems of dementia or delirium unless documented nonpharmacologic options (e.g., behavioral interventions) have failed and/or the patient is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid chronic use or persistent as-needed use.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",Moderate,Strong
Dementia or cognitive impairment,Ziprasidone,Antipsychotics,"Increased risk of stroke and greater rate of cognitive decline and mortality in people with dementia. 
Avoid antipsychotics for behavioral problems of dementia or delirium unless documented nonpharmacologic options (e.g., behavioral interventions) have failed and/or the patient is threatening substantial harm to self or others. 
If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.","Avoid chronic use or persistent as-needed use.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",Moderate,Strong
Dementia or cognitive impairment,Atropine,Antispasmodics,"Strong anticholinergic properties, uncertain effectiveness. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Clidinium/chlordiazepoxide,Antispasmodics,"Strong anticholinergic properties, uncertain effectiveness. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Dicyclomine,Antispasmodics,"Strong anticholinergic properties, uncertain effectiveness. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Homatropine,Antispasmodics,"Strong anticholinergic properties, uncertain effectiveness. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Hyoscyamine,Antispasmodics,"Strong anticholinergic properties, uncertain effectiveness. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Scopolamine,Antispasmodics,"Strong anticholinergic properties, uncertain effectiveness. 
Avoid because of adverse CNS effects. ",Avoid,Moderate,Strong
Dementia or cognitive impairment,Cyclobenzaprine,Skeletal muscle relaxants,"Strong anticholinergic properties. 
Avoid because of adverse CNS effects. 
Muscle relaxants typically used to treat musculoskeletal complaints are poorly tolerated by older adults due to anticholinergic adverse effects, sedation, and increased risk of fractures; effectiveness at dosages tolerated by older adults is questionable.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Orphenadrine,Skeletal muscle relaxants,"Strong anticholinergic properties. 
Avoid because of adverse CNS effects. 
Muscle relaxants typically used to treat musculoskeletal complaints are poorly tolerated by older adults due to anticholinergic adverse effects, sedation, and increased risk of fractures; effectiveness at dosages tolerated by older adults is questionable.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Alprazolam,Benzodiazepines ,"Avoid because of adverse CNS effects. 
The use of benzodiazepines exposes users to risks of abuse, misuse, and addiction. Concomitant use of opioids may result in profound sedation, respiratory depression, coma, and death.

Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; the continued use of benzodiazepines may lead to clinically significant physical dependence. In general, all benzodiazepines increase the risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults.

May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Chlordiazepoxide,Benzodiazepines ,"Avoid because of adverse CNS effects. 
The use of benzodiazepines exposes users to risks of abuse, misuse, and addiction. Concomitant use of opioids may result in profound sedation, respiratory depression, coma, and death.

Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; the continued use of benzodiazepines may lead to clinically significant physical dependence. In general, all benzodiazepines increase the risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults.

May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia.",Avoid chlordiazepoxide alone/ in combination with amitriptyline or clidinium.,Moderate,Strong
Dementia or cognitive impairment,Clobazam,Benzodiazepines ,"Avoid because of adverse CNS effects. 
The use of benzodiazepines exposes users to risks of abuse, misuse, and addiction. Concomitant use of opioids may result in profound sedation, respiratory depression, coma, and death.

Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; the continued use of benzodiazepines may lead to clinically significant physical dependence. In general, all benzodiazepines increase the risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults.

May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Clonazepam,Benzodiazepines ,"Avoid because of adverse CNS effects. 
The use of benzodiazepines exposes users to risks of abuse, misuse, and addiction. Concomitant use of opioids may result in profound sedation, respiratory depression, coma, and death.

Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; the continued use of benzodiazepines may lead to clinically significant physical dependence. In general, all benzodiazepines increase the risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults.

May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Clorazepate,Benzodiazepines ,"Avoid because of adverse CNS effects. 
The use of benzodiazepines exposes users to risks of abuse, misuse, and addiction. Concomitant use of opioids may result in profound sedation, respiratory depression, coma, and death.

Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; the continued use of benzodiazepines may lead to clinically significant physical dependence. In general, all benzodiazepines increase the risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults.

May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Diazepam,Benzodiazepines ,"Avoid because of adverse CNS effects. 
The use of benzodiazepines exposes users to risks of abuse, misuse, and addiction. Concomitant use of opioids may result in profound sedation, respiratory depression, coma, and death.

Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; the continued use of benzodiazepines may lead to clinically significant physical dependence. In general, all benzodiazepines increase the risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults.

May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Estazolam,Benzodiazepines ,"Avoid because of adverse CNS effects. 
The use of benzodiazepines exposes users to risks of abuse, misuse, and addiction. Concomitant use of opioids may result in profound sedation, respiratory depression, coma, and death.

Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; the continued use of benzodiazepines may lead to clinically significant physical dependence. In general, all benzodiazepines increase the risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults.

May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Lorazepam,Benzodiazepines ,"Avoid because of adverse CNS effects. 
The use of benzodiazepines exposes users to risks of abuse, misuse, and addiction. Concomitant use of opioids may result in profound sedation, respiratory depression, coma, and death.

Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; the continued use of benzodiazepines may lead to clinically significant physical dependence. In general, all benzodiazepines increase the risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults.

May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Midazolam,Benzodiazepines ,"Avoid because of adverse CNS effects. 
The use of benzodiazepines exposes users to risks of abuse, misuse, and addiction. Concomitant use of opioids may result in profound sedation, respiratory depression, coma, and death.

Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; the continued use of benzodiazepines may lead to clinically significant physical dependence. In general, all benzodiazepines increase the risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults.

May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Oxazepam,Benzodiazepines ,"Avoid because of adverse CNS effects. 
The use of benzodiazepines exposes users to risks of abuse, misuse, and addiction. Concomitant use of opioids may result in profound sedation, respiratory depression, coma, and death.

Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; the continued use of benzodiazepines may lead to clinically significant physical dependence. In general, all benzodiazepines increase the risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults.

May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Temazepam,Benzodiazepines ,"Avoid because of adverse CNS effects. 
The use of benzodiazepines exposes users to risks of abuse, misuse, and addiction. Concomitant use of opioids may result in profound sedation, respiratory depression, coma, and death.

Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; the continued use of benzodiazepines may lead to clinically significant physical dependence. In general, all benzodiazepines increase the risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults.

May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Triazolam,Benzodiazepines ,"Avoid because of adverse CNS effects. 
The use of benzodiazepines exposes users to risks of abuse, misuse, and addiction. Concomitant use of opioids may result in profound sedation, respiratory depression, coma, and death.

Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; the continued use of benzodiazepines may lead to clinically significant physical dependence. In general, all benzodiazepines increase the risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults.

May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Flurazepam,Benzodiazepines ,"Avoid because of adverse CNS effects. 
The use of benzodiazepines exposes users to risks of abuse, misuse, and addiction. Concomitant use of opioids may result in profound sedation, respiratory depression, coma, and death.

Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; the continued use of benzodiazepines may lead to clinically significant physical dependence. In general, all benzodiazepines increase the risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults.

May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, and periprocedural anesthesia.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Eszopiclone,"Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (""Z-drugs"") ","Avoid because of adverse CNS effects.
Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (Z-drugs) have adverse events similar to those of benzodiazepines in older adults (e.g., delirium, falls, fractures, increased emergency room visits/ hospitalizations, motor vehicle crashes); minimal improvement in sleep latency and duration.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Zaleplon,"Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (""Z-drugs"") ","Avoid because of adverse CNS effects.
Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (Z-drugs) have adverse events similar to those of benzodiazepines in older adults (e.g., delirium, falls, fractures, increased emergency room visits/ hospitalizations, motor vehicle crashes); minimal improvement in sleep latency and duration.",Avoid,Moderate,Strong
Dementia or cognitive impairment,Zolpidem,"Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (""Z-drugs"") ","Avoid because of adverse CNS effects.
Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (Z-drugs) have adverse events similar to those of benzodiazepines in older adults (e.g., delirium, falls, fractures, increased emergency room visits/ hospitalizations, motor vehicle crashes); minimal improvement in sleep latency and duration.",Avoid,Moderate,Strong
History of falls or fractures,Amitriptyline,Tricyclic antidepressants,"Strong anticholinergic properties. 
Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
May cause ataxia, impaired psychomotor function,
syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Amoxapine,Tricyclic antidepressants,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
May cause ataxia, impaired psychomotor function,
syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Clomipramine,Tricyclic antidepressants,"Strong anticholinergic properties. 
Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
May cause ataxia, impaired psychomotor function,
syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Desipramine,Tricyclic antidepressants,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Doxepin,Tricyclic antidepressants,"<=6mg/day: Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
>6mg/day:
Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Imipramine,Tricyclic antidepressants,"Strong anticholinergic properties. 
Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Nortriptyline,Tricyclic antidepressants,"Strong anticholinergic properties. 
Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Paroxetine,Selective serotonin re-uptake inhibitors,"Strong anticholinergic properties. 
Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Duloxetine,Serotonin and norepinephrine reuptake inhibitors,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Venlafaxine,Serotonin and norepinephrine reuptake inhibitors,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Desvenlafaxine,Serotonin and norepinephrine reuptake inhibitors,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Escitalopram,Selective serotonin re-uptake inhibitors,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Fluvoxetine,Selective serotonin re-uptake inhibitors,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Fluvoxamine,Selective serotonin re-uptake inhibitors,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Sertraline,Selective serotonin re-uptake inhibitors,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Vortioxetine,Selective serotonin re-uptake inhibitors,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Citalopram,Selective serotonin re-uptake inhibitors,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Dapoxetine,Selective serotonin re-uptake inhibitors,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Trazodone,Selective serotonin re-uptake inhibitors,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Dothiepin,Tricyclic antidepressants,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Dosulepin,Tricyclic antidepressants,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Protriptyline,Tricyclic antidepressants,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Tianeptine,Tricyclic antidepressants,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Trimipramine,Tricyclic antidepressants,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Melitracen,Tricyclic antidepressants,"Evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,Moderate,Strong
History of falls or fractures,Prochlorperazine,Antiemetics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Promethazine,"Antiemetics, First-generation antihistamines","Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Brompheniramine,First-generation antihistamines,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Chlorpheniramine,First-generation antihistamines,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Cyproheptadine,First-generation antihistamines,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Dimenhydrinate,First-generation antihistamines,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Diphenhydramine,First-generation antihistamines,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Doxylamine,First-generation antihistamines,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Hydroxyzine,First-generation antihistamines,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Meclizine,First-generation antihistamines,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Triprolidine,First-generation antihistamines,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Darifenacin,Antimuscarinics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Fesoterodine,Antimuscarinics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Flavoxate,Antimuscarinics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Oxybutynin,Antimuscarinics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Solifenacin,Antimuscarinics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Tolterodine,Antimuscarinics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Trospium,Antimuscarinics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Benztropine,Antiparkinsonian agents,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Trihexyphenidyl,Antiparkinsonian agents,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Chlorpromazine,Antipsychotics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.","Avoid unless safer alternatives are not available.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",High,Strong
History of falls or fractures,Clozapine,Antipsychotics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.","Avoid unless safer alternatives are not available.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",High,Strong
History of falls or fractures,Olanzapine,Antipsychotics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.","Avoid unless safer alternatives are not available.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",High,Strong
History of falls or fractures,Perphenazine,Antipsychotics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.","Avoid unless safer alternatives are not available.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",High,Strong
History of falls or fractures,Fluphenazine,Antipsychotics,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.","Avoid unless safer alternatives are not available.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",High,Strong
History of falls or fractures,Haloperidol,Antipsychotics,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.","Avoid unless safer alternatives are not available.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",High,Strong
History of falls or fractures,Aripiprazole,Antipsychotics,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.","Avoid unless safer alternatives are not available.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",High,Strong
History of falls or fractures,Brexpiprazole,Antipsychotics,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.","Avoid unless safer alternatives are not available.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",High,Strong
History of falls or fractures,Cariprazine,Antipsychotics,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.","Avoid unless safer alternatives are not available.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",High,Strong
History of falls or fractures,Lurasidone,Antipsychotics,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.","Avoid unless safer alternatives are not available.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",High,Strong
History of falls or fractures,Paliperidone,Antipsychotics,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.","Avoid unless safer alternatives are not available.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",High,Strong
History of falls or fractures,Pimavanserin,Antipsychotics,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.","Avoid unless safer alternatives are not available.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",High,Strong
History of falls or fractures,Quetiapine,Antipsychotics,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.","Avoid unless safer alternatives are not available.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",High,Strong
History of falls or fractures,Risperidone,Antipsychotics,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.","Avoid unless safer alternatives are not available.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",High,Strong
History of falls or fractures,Ziprasidone,Antipsychotics,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.","Avoid unless safer alternatives are not available.

May be required to treat concurrent schizophrenia, bipolar disorder, and other selected mental health and neuropsychiatric conditions but should be prescribed in the lowest effective dose and for the shortest possible duration.",High,Strong
History of falls or fractures,Atropine,Antispasmodics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Clidinium/chlordiazepoxide,Antispasmodics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Dicyclomine,Antispasmodics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Homatropine,Antispasmodics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Hyoscyamine,Antispasmodics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Scopolamine,Antispasmodics,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Cyclobenzaprine,Skeletal muscle relaxants,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Orphenadrine,Skeletal muscle relaxants,"Strong anticholinergic properties. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Carbamazepine,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Phenytoin,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Valproic acid,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Valproate,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Phenobarbitone,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Perampanel,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Levetiracetam,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Topiramate,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Lamotrigine,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Zonisamide,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Lacosamide,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Eslicarbazepine,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Rufinamide,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Cannabidiol ,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Gabapentin,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Pregabalin,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Oxcarbazepine,Antiepileptics ,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for seizures and mood disorders.,High,Strong
History of falls or fractures,Clonazepam,Benzodiazepines ,"Shorter-acting ones are not safer than long-acting ones. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Lorazepam,Benzodiazepines ,"Shorter-acting ones are not safer than long-acting ones. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Diazepam,Benzodiazepines ,"Shorter-acting ones are not safer than long-acting ones. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Alprazolam,Benzodiazepines ,"Shorter-acting ones are not safer than long-acting ones. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Chlordiazepoxide,Benzodiazepines ,"Shorter-acting ones are not safer than long-acting ones. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid chlordiazepoxide alone/ in combination with amitriptyline or clidinium unless safer alternatives are not available.,High,Strong
History of falls or fractures,Clobazam,Benzodiazepines ,"Shorter-acting ones are not safer than long-acting ones. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Clorazepate,Benzodiazepines ,"Shorter-acting ones are not safer than long-acting ones. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Estazolam,Benzodiazepines ,"Shorter-acting ones are not safer than long-acting ones. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Midazolam,Benzodiazepines ,"Shorter-acting ones are not safer than long-acting ones. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Oxazepam,Benzodiazepines ,"Shorter-acting ones are not safer than long-acting ones. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Temazepam,Benzodiazepines ,"Shorter-acting ones are not safer than long-acting ones. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Triazolam,Benzodiazepines ,"Shorter-acting ones are not safer than long-acting ones. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Flurazepam,Benzodiazepines ,"Shorter-acting ones are not safer than long-acting ones. 
May cause ataxia, impaired psychomotor function, syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Eszopiclone,"Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (""Z-drugs"") ","May cause ataxia, impaired psychomotor function, syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Zaleplon,"Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (""Z-drugs"") ","May cause ataxia, impaired psychomotor function, syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Zolpidem,"Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (""Z-drugs"") ","May cause ataxia, impaired psychomotor function, syncope, or additional falls.
If the drug must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid unless safer alternatives are not available.,High,Strong
History of falls or fractures,Morphine,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
History of falls or fractures,Methadone,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
History of falls or fractures,Oxycodone,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
History of falls or fractures,Fentanyl ,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
History of falls or fractures,Codeine,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
History of falls or fractures,Tramadol,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
History of falls or fractures,Oxymorphone,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
History of falls or fractures,Buprenorphine,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
History of falls or fractures,Meperidine,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
History of falls or fractures,Pethidine,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
History of falls or fractures,Hydromorphone,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
History of falls or fractures,Tapentadol,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
History of falls or fractures,Hydrocodone,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
History of falls or fractures,Remifentanil,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
History of falls or fractures,Alfentanil,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
History of falls or fractures,Pentazocine,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
History of falls or fractures,Sufentanil,Opioids,"May cause ataxia, impaired psychomotor function, syncope, or additional falls. 
If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.",Avoid except for pain management in the setting of severe acute pain.,Moderate,Strong
Parkinsonism,Metoclopramide,"Antiemetics, Dopamine receptor agonists",Dopamine-receptor antagonists with the potential to worsen parkinsonian symptoms.,Avoid,Moderate,Strong
Parkinsonism,Prochlorperazine,Antiemetics,Dopamine-receptor antagonists with the potential to worsen parkinsonian symptoms.,Avoid,Moderate,Strong
Parkinsonism,Promethazine,"Antiemetics, First-generation antihistamines",Dopamine-receptor antagonists with the potential to worsen parkinsonian symptoms.,Avoid,Moderate,Strong
Parkinsonism,Chlorpromazine,Antipsychotics,"Strong anticholinergic properties. 
Dopamine-receptor antagonists with the potential to worsen parkinsonian symptoms.",Avoid,Moderate,Strong
Parkinsonism,Olanzapine,Antipsychotics,"Strong anticholinergic properties. 
Dopamine-receptor antagonists with the potential to worsen parkinsonian symptoms.",Avoid,Moderate,Strong
Parkinsonism,Perphenazine,Antipsychotics,"Strong anticholinergic properties. 
Dopamine-receptor antagonists with the potential to worsen parkinsonian symptoms.",Avoid,Moderate,Strong
Parkinsonism,Fluphenazine,Antipsychotics,Dopamine-receptor antagonists with the potential to worsen parkinsonian symptoms.,Avoid,Moderate,Strong
Parkinsonism,Haloperidol,Antipsychotics,Dopamine-receptor antagonists with the potential to worsen parkinsonian symptoms.,Avoid,Moderate,Strong
Parkinsonism,Aripiprazole,Antipsychotics,Dopamine-receptor antagonists with the potential to worsen parkinsonian symptoms.,Avoid,Moderate,Strong
Parkinsonism,Brexpiprazole,Antipsychotics,Dopamine-receptor antagonists with the potential to worsen parkinsonian symptoms.,Avoid,Moderate,Strong
Parkinsonism,Cariprazine,Antipsychotics,Dopamine-receptor antagonists with the potential to worsen parkinsonian symptoms.,Avoid,Moderate,Strong
Parkinsonism,Lurasidone,Antipsychotics,Dopamine-receptor antagonists with the potential to worsen parkinsonian symptoms.,Avoid,Moderate,Strong
Parkinsonism,Paliperidone,Antipsychotics,Dopamine-receptor antagonists with the potential to worsen parkinsonian symptoms.,Avoid,Moderate,Strong
Parkinsonism,Risperidone,Antipsychotics,Dopamine-receptor antagonists with the potential to worsen parkinsonian symptoms.,Avoid,Moderate,Strong
Parkinsonism,Ziprasidone,Antipsychotics,Dopamine-receptor antagonists with the potential to worsen parkinsonian symptoms.,Avoid,Moderate,Strong
History of ulcer of stomach or duodenum,Aspirin,"Non-steroidal anti-inflammatory drugs, non-COX-2-selective, Antiplatelets",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Ibuprofen,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Naproxen,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Diclofenac,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Mefenamic acid,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Ketoprofen,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Diflunisal ,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Etodolac,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Flurbiprofen,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Indomethacin,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Ketorolac ,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Meloxicam ,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Nabumetone,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Oxaprozin,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Piroxicam ,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Sulindac,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Choline salicylate,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Methyl salicylate,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Sodium salicylate,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Dexketoprofen,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Aceclofenac,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Fenoprofen,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Phenylbutazone,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Meclofenamic acid,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
History of ulcer of stomach or duodenum,Meclofenamate,"Non-steroidal anti-inflammatory drugs, non-COX-2 selective",May exacerbate existing ulcers or cause new/additional ulcers.,"Avoid unless other alternatives are not effective and the patient can take a gastroprotective agent (i.e., proton-pump inhibitor or misoprostol).",Moderate,Strong
"Urinary incontinence
(all types) in women",Doxazosin,Non-selective peripheral alpha-1 blockers,Aggravation of incontinence.,Avoid in women. Avoid use as an antihypertensive.,Moderate,Strong
"Urinary incontinence
(all types) in women",Prazosin,Non-selective peripheral alpha-1 blockers,Aggravation of incontinence.,Avoid in women. Avoid use as an antihypertensive.,Moderate,Strong
"Urinary incontinence
(all types) in women",Terazosin,Non-selective peripheral alpha-1 blockers,Aggravation of incontinence.,Avoid in women. Avoid use as an antihypertensive.,Moderate,Strong
"Urinary incontinence
(all types) in women",Tamsulosin,Selective peripheral alpha-1 blockers,Aggravation of incontinence.,"Avoid in women. Avoid use as an antihypertensive.

Data are limited for selective peripheral alpha-1 blockers (e.g., tamsulosin, silodosin, and others) but may apply as well.",Moderate,Strong
"Urinary incontinence
(all types) in women",Silodosin,Selective peripheral alpha-1 blockers,Aggravation of incontinence.,"Avoid in women. Avoid use as an antihypertensive.

Data are limited for selective peripheral alpha-1 blockers (e.g., tamsulosin, silodosin, and others) but may apply as well.",Moderate,Strong
"Urinary incontinence
(all types) in women",Alfuzosin,Selective peripheral alpha-1 blockers,Aggravation of incontinence.,"Avoid in women. Avoid use as an antihypertensive.

Data are limited for selective peripheral alpha-1 blockers (e.g., tamsulosin, silodosin, and others) but may apply as well.",Moderate,Strong
"Urinary incontinence
(all types) in women",Conjugated estrogens,Estrogens,Lack of efficacy. (oral estrogen),"Oral:
Avoid in women. Also, consider deprescribing among older women already using this medication.",High,Strong
"Urinary incontinence
(all types) in women",Estradiol ,Estrogens,Lack of efficacy. (oral estrogen),"Oral and transdermal:
Avoid in women. Also, consider deprescribing among older women already using this medication.",High,Strong
"Urinary incontinence
(all types) in women",Ethinyl estradiol,Estrogens,Lack of efficacy. (oral estrogen),"Oral:
Avoid in women. Also, consider deprescribing among older women already using this medication.",High,Strong
"Urinary incontinence
(all types) in women",Estropipate ,Estrogens,Lack of efficacy. (oral estrogen),"Oral:
Avoid in women. Also, consider deprescribing among older women already using this medication.",High,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Amitriptyline,Tricyclic antidepressants,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Amoxapine,Tricyclic antidepressants,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Clomipramine,Tricyclic antidepressants,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Desipramine,Tricyclic antidepressants,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Doxepin ,Tricyclic antidepressants,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid >6 mg/day in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Imipramine,Tricyclic antidepressants,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Nortriptyline,Tricyclic antidepressants,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Paroxetine,Selective serotonin re-uptake inhibitors,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Prochlorperazine,Antiemetics,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Promethazine,"Antiemetics, First-generation antihistamines",Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Brompheniramine,First-generation antihistamines,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Chlorpheniramine,First-generation antihistamines,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Cyproheptadine,First-generation antihistamines,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Dimenhydrinate,First-generation antihistamines,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Diphenhydramine,First-generation antihistamines,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Doxylamine,First-generation antihistamines,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Hydroxyzine,First-generation antihistamines,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Meclizine,First-generation antihistamines,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Triprolidine,First-generation antihistamines,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Benztropine,Antiparkinsonian agents,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Trihexyphenidyl,Antiparkinsonian agents,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Chlorpromazine,Antipsychotics,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Clozapine,Antipsychotics,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Olanzapine,Antipsychotics,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Perphenazine,Antipsychotics,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Atropine,Antispasmodics,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Clidinium/chlordiazepoxide,Antispasmodics,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Dicyclomine,Antispasmodics,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Homatropine,Antispasmodics,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Hyoscyamine,Antispasmodics,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Scopolamine,Antispasmodics,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Cyclobenzaprine,Skeletal muscle relaxants,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
"Lower urinary tract symptoms, hyperplasia of prostate",Orphenadrine,Skeletal muscle relaxants,Strong anticholinergic properties. May decrease urinary flow and cause urinary retention.,Avoid in men,Moderate,Strong
